Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.8B | 4.9B | 4.9B | 5.1B |
Cost of revenue | 3.9B | 3.9B | 4.0B | 4.1B |
Gross profit | 920M | 962M | 903M | 968M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 384M | 363M | 331M | 405M |
Other operating expenses | — | — | — | — |
Operating income | 485M | 547M | 519M | 511M |
Non operating interest income | ||||
Income | 11M | 20M | 31M | 16M |
Expense | 93M | 107M | 101M | 64M |
Other income expense | -48M | -113M | -42M | 565M |
Pretax income | 355M | 347M | 407M | 1.0B |
Tax provision | 356M | 64M | 32M | 51M |
Net income | -11M | 275M | 368M | 943M |
Basic EPS | -0.1 | 1.1 | 1.5 | 3.5 |
Diluted EPS | -0.1 | 1.1 | 1.5 | 3.5 |
Basic average shares | 230.2M | 235.0M | 245.5M | 270.2M |
Diluted average shares | 230.2M | 235.5M | 245.8M | 270.4M |
EBITDA | 732M | 1.4B | 782M | 766M |
Net income from continuing op. | -11M | 275M | 368M | 943M |
Minority interests | 0 | -7M | -5M | -5M |
Preferred stock dividends | — | — | — | — |